Lonestar Heart

About:

LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate functioning of a human heart.

Website: http://www.lonestarheartinc.com

Top Investors: Themes Investment Partners

Description:

LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). Based on its integrated card mechanical and biomolecular technologies, the privately-held company is developing a broad portfolio of products to restore the failing heart’s structure and function in collaboration with the University of Texas Southwestern Medical Center, Texas Heart Institute, and a global network of leading clinicians. These products include Algisyl-LVR, small molecule cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company’s proprietary biopolymer hydrogel matrix system.

Total Funding Amount:

$47.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Laguna Hills, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)lshmail.com

Founders:

Eric Newell Olson, James T. Willerson

Number of Employees:

11-50

Last Funding Date:

2014-09-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai